I agree that this site is using cookies. You can find further informations here.
X
Tauchi, Tetsuzo
93  results:
Search for persons X
?
1

Nilotinib vs. Dasatinib in Achieving MR4.5 for de novo Chro..:

Matsumura, Itaru ; Ohtake, Shigeki ; Atsuta, Yoshiko...
Blood Advances.  , 2024
Link: https://doi.org/10.1182/..
 
?
2

Glasdegib Plus Intensive/Nonintensive Chemotherapy in Untre..:

Cortes, Jorge E ; Dombret, Hervé ; Merchant, Akil...
Future Oncology.  15 (2019)  31 - p. 3531-3545 , 2019
Link: https://doi.org/10.2217/..
 
?
3

Corrigendum to "Phase 1/2 trial of glasdegib in patients wi..:

Gerds, Aaron T. ; Tauchi, Tetsuzo ; Ritchie, Ellen...
Leukemia Research.  81 (2019)  - p. 105 , 2019
Link: https://doi.org/10.1016/..
 
?
4

Phase 1/2 trial of glasdegib in patients with primary or se..:

Gerds, Aaron T. ; Tauchi, Tetsuzo ; Ritchie, Ellen...
Leukemia Research.  79 (2019)  - p. 38-44 , 2019
Link: https://doi.org/10.1016/..
 
?
5

Copanlisib, a novel phosphoinositide 3-kinase inhibitor, co..:

Okabe, Seiichi ; Tanaka, Yuko ; Tauchi, Tetsuzo.
Annals of Hematology.  98 (2018)  3 - p. 723-733 , 2018
Link: https://doi.org/10.1007/..
 
?
6

Therapeutic effects of tyrosine kinase inhibitors and subty..:

Inokuchi, Koiti ; Nakayama, Kazutaka ; Tauchi, Tetsuzo...
Leukemia Research.  65 (2018)  - p. 74-79 , 2018
Link: https://doi.org/10.1016/..
 
?
7

Therapeutic targeting of Aurora A kinase in Philadelphia ch..:

Okabe, Seiichi ; Tauchi, Tetsuzo ; Tanaka, Yuko.
Oncotarget.  9 (2018)  65 - p. 32496-32506 , 2018
Link: https://doi.org/10.18632..
 
?
8

A novel strategy for ABL tyrosine kinase inhibitor resistan..:

Okabe, Seiichi ; Tauchi, Tetsuzo ; Tanaka, Yuko.
Experimental Hematology.  53 (2017)  - p. S73 , 2017
Link: https://doi.org/10.1016/..
 
?
9

Deeper molecular response is a predictive factor for treatm..:

The Japan Adult Leukemia Study Group ; Takahashi, Naoto ; Tauchi, Tetsuzo...
International Journal of Hematology.  107 (2017)  2 - p. 185-193 , 2017
Link: https://doi.org/10.1007/..
 
?
10

Up-regulated exosomal miRNA-140-3p in CML patients with mus..:

Asano, Michiyo ; Umezu, Tomohiro ; Katagiri, Seiichiro...
International Journal of Hematology.  105 (2017)  4 - p. 419-422 , 2017
Link: https://doi.org/10.1007/..
 
?
11

Ponatinib in Japanese patients with Philadelphia chromosome..:

Tojo, Arinobu ; Kyo, Taiichi ; Yamamoto, Kazuhito...
International Journal of Hematology.  106 (2017)  3 - p. 385-397 , 2017
Link: https://doi.org/10.1007/..
 
?
12

Evaluation of the dose and efficacy of ruxolitinib in Japan..:

Kirito, Keita ; Okamoto, Shinichiro ; Ohishi, Kohshi...
International Journal of Hematology.  107 (2017)  1 - p. 92-97 , 2017
Link: https://doi.org/10.1007/..
 
?
13

Low body weight and body mass index may be associated with ..:

Katagiri, Seiichiro ; Tauchi, Tetsuzo ; Ando, Keiko...
Leukemia Research Reports.  7 (2017)  - p. 33-35 , 2017
Link: https://doi.org/10.1016/..
 
?
14

Combination therapy with copanlisib and ABL tyrosine kinase..:

Okabe, Seiichi ; Tauchi, Tetsuzo ; Tanaka, Yuko..
Oncotarget.  7 (2016)  33 - p. 53116-53126 , 2016
Link: https://doi.org/10.18632..
 
?
15

Downregulation of Plasma miR-215 in Chronic Myeloid Leukemi..:

Ohyashiki, Kazuma ; Umezu, Tomohiro ; Katagiri, Seiichiro...
International Journal of Molecular Sciences.  17 (2016)  4 - p. 570 , 2016
Link: https://doi.org/10.3390/..
 
1-15